期刊文献+

精蛋白锌重组赖脯胰岛素混合注射液(50R)强化治疗初诊2型糖尿病疗效观察 被引量:16

Therapeutic effect of intensification therapy with insulin lispro mix 50/50 on the preliminarily diagnosed type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨初诊2型糖尿病患者应用精蛋白锌重组赖脯胰岛素混合注射液(50R)(优泌乐50)强化治疗的效果和用药依从性。方法 72例初诊2型糖尿病患者随机分为对照组37例和观察组35例。对照组于三餐前15min皮下注射门冬胰岛素,晚22:00皮下注射甘精胰岛素;观察组三餐前15min皮下注射优泌乐50;2组均连续用药14d。检测2组治疗前、治疗14d后空腹血糖(fasting plasma glucose,FPG)、餐后2h血糖(2-hour plasma glucose,2hPG);出院后随访2个月,记录2组自行停药患者比率。结果观察组治疗14d后FPG[(6.54±0.81)mmol/L]、2hPG[(9.66±1.24)mmol/L]较治疗前[(12.22±3.91)、(17.87±3.47)mmol/L]降低(P<0.05);对照组治疗14d后FPG[(6.43±0.73)mmol/L]、2hPG[(9.27±1.18)mmol/L]较治疗前[(12.52±4.03)、(17.82±3.54)mmol/L]降低(P<0.05);2组治疗14d后FPG、2hPG水平比较差异无统计学意义(P>0.05);观察组胰岛素日用量与对照组比较差异无统计学意义(P>0.05);出院后2个月,对照组自行停药患者比率(40.5%)高于观察组(17.1%)(P<0.01)。结论初诊2型糖尿病患者应用优泌乐50强化治疗血糖控制效果满意,患者出院后治疗依从性较高。 Objective To discuss the therapeutic effect of intensification therapy by insulin lispro mix 50/50 on the preliminarily diagnosed type 2 diabetes mellitus(T2DM)and its compliance.Methods Seventy-two patients with preliminarily diagnosed T2DM were randomly divided into control group(n=37)and observation group(n=35).Control group received subcutaneous injection of insulin aspart 15 min before three meals and subcutaneous injection of insulin glargine at 22:00.Observation group received subcutaneous injection of insulin lispro mix 50/50 before three meals.Both two groups were treated for 14 days.The fasting plasma glucose(FPG)and 2-hour postprandial glucose(2hPG)were detected before and after 14-day treatment in both two groups.All patients were followed up for 2 months after discharge,and the proportions of drug withdrawal patients were recorded in two groups.Results The levels of FPG((6.54±0.81)mmol/L)and 2hPG((9.66±1.24)mmol/L)after 14-day treatment were significantly lower than those before treatment((12.22±3.91),(17.87±3.47)mmol/L)in observation group(P〈0.01).The levels of FPG((6.43±0.73)mmol/L)and 2hPG((9.27±1.18)mmol/L)after 14-day treatment were also significantly lower than those before treatment((12.52±4.03),(17.82±3.54)mmol/L)in control group(P〈0.05).There were no significant differences in the levels of FPG and 2hPG after 14-day treatment between two groups(P0.05).There was no significant differences in the daily dosage of insulin between observation group and control group(P〉0.05).The proportion of drug withdrawal patients was significantly higher in control group(40.5%)than that in observation group(17.1%)(P〉0.01).Conclusion Insulin lispro mix 50/50 is effective for controlling plasma glucose in patients with preliminarily diagnosed T2DM and the compliance is fine after discharge.
出处 《中华实用诊断与治疗杂志》 2016年第4期407-408,共2页 Journal of Chinese Practical Diagnosis and Therapy
基金 广西自然科学基金(2011GXNSFA018257)
关键词 2型糖尿病 精蛋白锌重组赖脯胰岛素混合注射液(50R) 空腹血糖 餐后2H血糖 Type 2diabetes mellitus insulin lispro mix 50/50 fasting plasma glucose 2-hour postprandial glucose
  • 相关文献

参考文献6

二级参考文献29

  • 1CERIELLO A, QUAGLIARO L, PICONI L, et al. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment [ J ]. Diabetes, 2004,53 ( 3 ) : 701 - 710.
  • 2HANEFELD M, KOEHLER C, SCHAPER F,et al. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals[ J]. Atherosclerosis, 1999,144 ( 1 ) :229 - 235.
  • 3BONORA E, CORRAO G, BAGNARDI V,et al. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus [ J ]. Diabetologia, 2006,49 (5) :846 -854.
  • 4BARNETT AH. A review of bassl insulins[ J]. Diabet Med,2003, 20(11) :873 -885.
  • 5BOLLI GB. How to ameliorate the problem of hypoglycemia in intensive as well as non-intensive treatment of type 1 diabetes[ J]. Diabetes Care, 1999,22 ( Supple 2 ) : B43 - B52.
  • 6ROSENSTOCK J,AHMANN A J, COLON G,et al. Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents:prandial premixed (insulin lispro protamine suspension/lispro) versus basal ( glargine/lispro ) therapy [ J ]. Diabetes Care,2008,31 (1) :20 -25.
  • 7REVIRIEGO J, GOMIS R, MARANES JP,et al. Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the costeffectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia[ J]. Int J Clin Pract,2008,62 (7) :1026 - 1032.
  • 8SCHWARTZ S,ZAGAR AJ,ALTHOUSE SK,et al. A single-center, randomized, double-blind, three-way crossover study examining postchalienge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus [ J ]. Clin Ther ,2006 ,28 (10) : 1649 - 1657.
  • 9Prigeon R J,Jacobson R K,Porte D,et al. Effect of sulfonylurea withdrawal on proinsulin levels, B-cell function, and glucose disposal in subjects with non-insulin-dependent diabetes mellitus[J]. J Clin Endocrinol Metab,1996,81:3295.
  • 10Davies M J,Metcalfe J,Day J L,et al. Effect of sulphonylurea therapy on plasma insulin, intact ang 32/33. split proinsulin in subjects with type 2 diabetes mellitus[J]. Diabet Med, 1994,11:293.

共引文献2344

同被引文献110

引证文献16

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部